Lefosse and Machado Meyer act on R$1.2bn Blau Pharmaceuticals IPO
Lefosse Advogados acted as Brazilian special counsel to Banco Itaú BBA S.A., Banco Bradesco BBI S.A., Banco J.P. Morgan S.A., Citigroup Global Markets Brasil, Corretora de Câmbio, Títulos e Valores Mobiliários S.A., XP Investimentos Corretora de Câmbio, Títulos e Valores Mobiliários S.A. and Banco BTG Pactual S.A., in connection with the IPO of Blau Farmacêutica S.A., represented by Machado Meyer
Lefosse Advogados acted as Brazilian special counsel to the coordinators of the primary public offering of 27,299,078 common shares issued by Blau Farmacêutica S.A., represented by Machado Meyer law firm.
The IPO moved R$1.2 billion. Blau Farmacêutica is one of the main pharmaceutical companies in Latin America, responsible for producing highly complex drugs for human health. It is specialized in biotechnological and synthetic products for oncology, nephrology, hematology, and infectology, mong others.
Machado, Meyer, Sendacz e Opice Advogados team was represented by partners Alessandra Souza (pictured left), Gustavo Secaf Rebello (pictured center) and lawyers Alexandra Menescal Tupper Palhares, Renata Augusto Passos.
Simpson Thacher & Bartlett LLP also represented Blau Farmacêutica.
Lefosse Advogados represented the underwriters with a team composed of partner Luiz Octavio Lopes (pictured right), lawyer Luciana Moutinho and associates Rodrigo Paes de Barros, Leonardo Gaspar, Luana Pereira and Lara Maroni.
Shearman & Sterling LLP also represented the underwriters.
